Loading clinical trials...

Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT02161315

Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer

Steroid Aromatase Inhibitors and Non-Steroid Aromatase Inhibitors in Late Stage Breast Cancer is the recommended scheme in National Comprehensive Cancer Network (NCCN) guideline. In the past controlle...

Lead sponsor: Tianjin Medical University Cancer Institute and Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Yehui Shi, MD

CONTACT

022-23340123-1052 [email protected]

Related studies

COMPLETEDNA

Palliative Hypofractionated Radiotherapy in Advanced Incurable Breast Cancer

NCT03511781 · Carcinoma Breast Stage IV

COMPLETEDPhase 2

IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma

NCT02614833 · Adenocarcinoma Breast Stage IV

COMPLETEDPhase 2

Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer

NCT00669565 · Carcinoma Breast Stage IV

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 22, 2015Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment80

Start dateApr 2014

Last updatedDec 22, 2015

Condition

Carcinoma Breast Stage IV

Locations shown

Tianjin Medical University Cancer Institute and Hospital

Tianjin, Tianjin Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 22, 2015Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions